Alaunos Therapeutics, Inc. Gain (Loss) on Termination of Lease
Alaunos Therapeutics, Inc. (TCRT) reported Gain (Loss) on Termination of Lease of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnTerminationOfLease · last filed 2025-03-31
- Alaunos Therapeutics, Inc. gain (loss) on termination of lease for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Alaunos Therapeutics, Inc. gain (loss) on termination of lease for fiscal 2023 was $298.00K, a 124.06% increase from fiscal 2022.
- Alaunos Therapeutics, Inc. gain (loss) on termination of lease for fiscal 2022 was $133.00K.
- Alaunos Therapeutics, Inc. gain (loss) on termination of lease for fiscal 2021 was $0.00.
| Period end | Gain (Loss) on Termination of Lease 6 month | Gain (Loss) on Termination of Lease 9 month | Gain (Loss) on Termination of Lease 12 month |
|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-31 | ||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 | ||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-14 | ||
| 2023-12-31 | $298.00K 10-K · filed 2025-03-31 | ||
| 2023-09-30 | $245.00K 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | $245.00K 10-Q · filed 2024-08-14 | ||
| 2022-12-31 | $133.00K 10-K · filed 2024-04-01 | ||
| 2022-09-30 | $133.00K 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $133.00K 10-Q · filed 2023-08-14 | ||
| 2021-12-31 | $0.00 10-K · filed 2023-03-07 | ||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |